Liopharm Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Genactiv uses a colostrum drying method involving freezing and liofilization processes to maintain the bioactive levels of their products. Genactiv's products are based on two active ingredients: Colostrum and Milk clay. The company's main business activities include the production and sale of colostrum-based supplements and dermokosmetics.

Headquarters
Ul. Polna 13/3
Dabrowka; Wielkopolskie; Postal Code: 62-070

Contact Details: Purchase the Liopharm Sp. z o.o. report to view the information.

Website: http://www.genactiv.pl

Basic Information

Total Employees:

Purchase the Liopharm Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Liopharm Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Liopharm Sp. z o.o. report to view the information.

Incorporation Date:

December 12, 2005

Company Performance

Financial values in the chart are available after Liopharm Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

40.36%▲

Total operating revenue

37.46%▲

Operating profit (EBIT)

50.08%▲

EBITDA

52.08%▲

Net Profit (Loss) for the Period

40.69%▲

Total assets

-6.37%▼

Total equity

59.48%▲

Operating Profit Margin (ROS)

1.53%▲

Net Profit Margin

0.04%▲

Return on Equity (ROE)

-4.98%▼

Debt to Equity Ratio

-90.77%▼

Quick Ratio

-0.03%▼

Cash Ratio

0.21%▲

Liopharm Sp. z o.o. (Poland)